Gensight Biologics (XPAR:SIGHT) Other Current Payables : €1.79 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics Other Current Payables?

Gensight Biologics's Other Current Payables for the quarter that ended in Dec. 2023 was €1.79 Mil.

Gensight Biologics's quarterly Other Current Payables declined from Dec. 2022 (€3.61 Mil) to Jun. 2023 (€3.47 Mil) and declined from Jun. 2023 (€3.47 Mil) to Dec. 2023 (€1.79 Mil).

Gensight Biologics's annual Other Current Payables increased from Dec. 2021 (€2.45 Mil) to Dec. 2022 (€3.61 Mil) but then declined from Dec. 2022 (€3.61 Mil) to Dec. 2023 (€1.79 Mil).

Gensight Biologics Other Current Payables Historical Data

The historical data trend for Gensight Biologics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gensight Biologics Other Current Payables Chart

Gensight Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

1.27

2.64

2.45

3.61

1.79

Gensight Biologics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial															2.45	2.52	3.61	3.47	1.79

Gensight Biologics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Gensight Biologics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Gensight Biologics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Gensight Biologics (XPAR:SIGHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (XPAR:SIGHT) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

GSGTF:USA G49N:Germany

Address

74,rue du Faubourg Saint-Antoine, Paris, FRA, 75012

Website

https://www.gensight-biologics.com

Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence, and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group focus is on ophthalmology where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics (XPAR:SIGHT) Headlines

No Headlines